Norethindrone sustained release formulations and methods associated therewith

Details for Australian Patent Application No. 2003240942 (hide)

Owner WATSON PHARMACEUTICALS, INC.

Inventors Anigbogu, Angela; Quan, Danyi; Ruiz, Anna

Agent FB Rice

Pub. Number AU-A-2003240942

PCT Number PCT/US03/16933

PCT Pub. Number WO2003/101461

Priority 60/383,790 30.05.02 US

Filing date 30 May 2003

Wipo publication date 19 December 2003

International Classifications

A61K 031/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

C07J 001/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/383,790 30.05.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003240942

4 January 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240943-DVD PLAYER WITH ENHANCED CONNECTIVITY

2003240941-CARTRIDGE ARRANGEMENT, FLUID ANALYZER ARRANGEMENT, AND METHODS